FOXD2 and colorectal carcinoma: According to Zhu et al., CDC42 was enriched in colorectal cancer cells (CRC) by FOXD2-AS1 binding miR-185-5p, proposing that the FOXD2-AS1/miR-185-5p/CDC42 axis contributed to CRC progression [19].